Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cancer Cell cycle Kinases/phosphatases Cdks

Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)

Price and availability

284 784 ₸

Availability

Order now and get it on Tuesday March 02, 2021

Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR19546] to CDK1 (phospho T161)
  • Suitable for: WB, Dot blot, IHC-P, IP, ICC/IF
  • Reacts with: Mouse, Rat, Human

You may also be interested in

Indirubin, cyclin-dependent kinase and GSK-3 beta inhibitor (ab120960)
Product image
Anti-GSK3 beta + GSK3 alpha antibody [EPR18814-102] - BSA and Azide free (ab226169)
Product image
Anti-Cdk1 + Cdk2 + Cdk3 + Cdk5 (phospho Y15) antibody [EPR2233Y] (ab76146)
Product image
Recombinant Human CDK5RAP3 protein (ab201715)

Overview

  • Product name

    Anti-CDK1 (phospho T161) antibody [EPR19546]
    See all CDK1 primary antibodies
  • Description

    Rabbit monoclonal [EPR19546] to CDK1 (phospho T161)
  • Host species

    Rabbit
  • Specificity

    ab201008 also recognizes CDK2 (phospho T160) and CDK3 (phospho T160).
  • Tested Applications & Species

    Application Species
    ICC/IF
    Human
    IHC-P
    Rat
    Human
    IP
    Human
    WB
    Mouse
    Rat
    Human
    See all applications and species data
  • Immunogen

    Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • WB: HeLa treated with UV for 90 minutes, HeLa treated with UV for 90 minutes then with alkaline phosphatase for 1 hour, C6, C6 treated with alkaline phosphatase for 1 hour and NIH/3T3 whole cell lysate. IHC-P: Human tonsil and cervix cancer tissues; Rat testis tissue. ICC/IF: HeLa cells. IP: HeLa treated with 25J/m2 UV for 1-hour whole cell lysate.
  • General notes

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
  • Storage buffer

    pH: 7.2
    Preservative: 0.01% Sodium azide
    Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
  • Concentration information loading...
  • Purity

    Protein A purified
  • Clonality

    Monoclonal
  • Clone number

    EPR19546
  • Isotype

    IgG
  • Research areas

    • Cell Biology
    • Cell Cycle
    • Kinases/Phosphatases
    • Cdks
    • Neuroscience
    • Neurology process
    • Neural Signal Transduction
    • Neuroscience
    • Neurology process
    • Neurodegenerative disease
    • Other
    • Epigenetics and Nuclear Signaling
    • Cell cycle
    • Kinases/Phosphatases
    • Cdks

Images

  • Western blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Western blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    All lanes : Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008) at 1/1000 dilution

    Lane 1 : HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate
    Lane 2 : HeLa treated with UV for 90 minutes whole cell lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution

    Developed using the ECL technique.

    Predicted band size: 34 kDa
    Observed band size: 28,34 kDa
    why is the actual band size different from the predicted?


    Exposure time: 30 seconds


    Blocking/Dilution buffer: 5% NFDM/TBST.

  • Dot Blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Dot Blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)

    Dot blot analysis of CDK1 (phospho T161) labeled with ab201008 at 1/1000 dilution.

    Lane 1: CDK1 (phospho T161) phospho peptide.
    Lane 2: CDK1 non-phospho peptide.

    Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution was used as secondary antibody.

    Blocking and dilution buffer: 5% NFDM/TBST.

    Exposure time: 3 minutes.

  • Dot Blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Dot Blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)

    Dot blot analysis of CDK2 (phospho T160) labeled with ab201008 at 1/1000 dilution.

    Lane 1: CDK2 (phospho T160) phospho peptide.
    Lane 2: CDK2 non-phospho peptide.

    Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution was used as secondary antibody.

    Blocking and dilution buffer: 5% NFDM/TBST.

    Exposure time: 3 minutes.

  • Dot Blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Dot Blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)

    Dot blot analysis of CDK3 (phospho T160) labeled with ab201008 at 1/1000 dilution.

    Lane 1: CDK3 (phospho T160) phospho peptide.
    Lane 2: CDK3 non-phospho peptide.

    Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution was used as secondary antibody.

    Blocking and dilution buffer: 5% NFDM/TBST.

    Exposure time: 3 minutes.

  • Western blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Western blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    All lanes : Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008) at 1/1000 dilution

    Lane 1 : HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate
    Lane 2 : HeLa treated with UV for 90 minutes whole cell lysate
    Lane 3 : HeLa treated with UV for 90 minutes then with alkaline phosphatase for 1-hour whole cell lysate
    Lane 4 : HeLa treated with UV for 90 minutes then with alkaline phosphatase overnight whole cell lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution

    Developed using the ECL technique.

    Predicted band size: 34 kDa
    Observed band size: 28,34 kDa why is the actual band size different from the predicted?


    Exposure time: 15 seconds


    Blocking/Dilution buffer: 5% NFDM/TBST.

  • Western blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Western blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    All lanes : Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008) at 1/1000 dilution

    Lane 1 : C6 (rat glial tumor cell line) whole cell lysate
    Lane 2 : C6 treated with alkaline phosphatase for 1 hour whole cell lysate
    Lane 3 : C6 treated with alkaline phosphatase overnight whole cell lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution

    Developed using the ECL technique.

    Predicted band size: 34 kDa
    Observed band size: 28,34 kDa why is the actual band size different from the predicted?


    Exposure time: 10 seconds


    Blocking/Dilution buffer: 5% NFDM/TBST.

  • Western blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Western blot - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    All lanes : Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008) at 1/1000 dilution

    Lane 1 : NIH/3T3 (mouse embryo fibroblast cell line) whole cell lysate
    Lane 2 : C6 (rat glial tumor cell line) whole cell lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution

    Developed using the ECL technique.

    Predicted band size: 34 kDa
    Observed band size: 28 kDa why is the actual band size different from the predicted?


    Exposure time: 3 seconds


    Blocking/Dilution buffer: 5% NFDM/TBST.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)

    Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling CDK1 (phospho T161) with ab201008 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Nucleus and weak cytoplasm staining of germinal center from human tonsil is observed. Counter stained with Hematoxylin.

    Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

    Heat mediated antigen retrieval was performed with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)

    Immunohistochemical analysis of paraffin-embedded human cervix cancer tissue labeling CDK1 (phospho T161) with ab201008 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Nucleus and cytoplasm staining of cancer cells from human cervix cancer is observed [PMID: 15623629]. Counter stained with Hematoxylin.

    Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

    Heat mediated antigen retrieval was performed with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)

    Immunohistochemical analysis of paraffin-embedded rat testis tissue labeling CDK1 (phospho T161) with ab201008 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Nucleus and cytoplasm staining of rat testis is observed. Counter stained with Hematoxylin.

    Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.

    Heat mediated antigen retrieval was performed with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

  • Immunocytochemistry/ Immunofluorescence - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Immunocytochemistry/ Immunofluorescence - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)

    Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (human epithelial cell line from cervix adenocarcinoma) cells labeling CDK1 (phospho T161) with ab201008 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing specific signal in M phase cells. The signal decreased after treatment with lambda protein phosphatase 31°C for 5 hours.

    The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-Alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 dilution (red).

    Secondary antibody only control: Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/1000 dilution.

  • Immunoprecipitation - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Immunoprecipitation - Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)

    CDK1 (phospho T161) was immunoprecipitated from 0.35mg of HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab201008 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab201008 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

    Lane 1: HeLa treated with 25J/m2 UV for 1 hour whole cell lysate 10 µg (Input).
    Lane 2: ab201008 IP in HeLa treated with 25J/m2 UV for 1 hour whole cell lysate.
    Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab201008 in HeLa treated with 25J/m2 UV for 1 hour whole cell lysate.

    Blocking and dilution buffer and concentration: 5% NFDM/TBST.

    Exposure time: 3 minutes.

  • Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)
    Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-CDK1 (phospho T161) antibody [EPR19546] (ab201008)

  •  
  • Product image

    Anti-CDK1 (phospho T14) antibody (ab58509)

    Applications: ICC/IF, WB

  •  
  • Product image

    Anti-CDK1 antibody (ab221197)

    Applications: WB

  •  
  • Product image

    Anti-CDK1 antibody (ab245318)

    Applications: IP, WB

  •  
  • Product image

    Anti-CDK1 antibody (ab71939)

    Applications: WB

  •  
  • Product image

    Anti-CDK1 (phospho Y15) antibody (ab47594)

    Applications: WB

  •  
  • Product image

    Anti-CDK1 antibody [A17] - BSA and Azide free (ab264084)

    Applications: ELISA, Flow Cyt, ICC/IF, IHC-FoFr, IHC-Fr, IHC-P, IP, RIA, WB

  •  
  • Product image

    Anti-CDK1 antibody (ab131450)

    Applications: ICC/IF, IHC-P, WB

  •  
  • Product image

    Anti-CDK1 (phospho T161) antibody (ab47329)

    Applications: IHC-P, WB

  •  
  • Product image

    Anti-CDK1 antibody [A17.1.1] - BSA and Azide free (ab236309)

    Applications: IHC-P

Clear all

Recently viewed products

  •  
  • Product image

    Anti-IDH2 antibody [EPR7576] (ab129180)

  •  
  • Product image

    Anti-Glucose Transporter GLUT1 antibody [SP168] (ab150299)

  •  
  • Product image

    Anti-Myelin Basic Protein antibody [IGX3421R-1] (ab216668)

  •  
  • Product image

    Anti-Oct-2 antibody [9A2] (ab243153)

  •  
  • Product image

    Anti-CD42b antibody [EPR6995] (ab134087)

  •  
  • Product image

    Anti-BPI antibody [EPR12350(B)] (ab175231)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.